Toast Inc. Class A Common Stock vs GeneDx Holdings Corp — how do they compare? Toast Inc. Class A Common Stock trades at $29.99 (market cap $17.25B), while GeneDx Holdings Corp trades at $68.61 (market cap $2.04B). The key difference: Toast Inc. Class A Common Stock is far larger — about 8.5× GeneDx Holdings Corp's market cap, and Toast Inc. Class A Common Stock is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Toast Inc. Class A Common Stock for 0 Days and GeneDx Holdings Corp for 20 Days on average.
| TOST | WGS | |
|---|---|---|
Market Cap | $17.25B | $2.04B |
Volume | 10,274,535 | 962,082 |
Sector | Technology | Health |
52-Week High | $39.02 | $167.51 |
52-Week Low | $22.33 | $34.51 |
Typical Hold Time | 0 Days | 20 Days |
Enterprise Value | $15.50B | $2.08B |
Signals from Pluang's Aura AI — not financial advice
Toast (TOST) trades at $30.89, down 1.37% on the day, with neutral technical indicators showing support at $30 and resistance at $32. The company demonstrates strong fundamental performance with 23% revenue growth in Q2 2026 to $1.91B and expanding profit margins, though valuation metrics remain elevated with a P/E of 39.1. Recent expansion into convenience stores with Toast Fuel and AI-driven product enhancements signal continued growth initiatives.
The outlook remains positive with 61.8% analyst buy ratings and a $38.22 consensus price target representing 24% upside potential. Key risks include execution challenges in new market segments and competitive pressures in the restaurant technology space, while strong earnings beats and institutional support provide confidence in the growth trajectory.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Toast Inc. provides a cloud-based technology platform for the restaurant industry, combining point-of-sale hardware and software with payment processing, online ordering, payroll, and supplier management tools. The platform serves restaurants ranging from single locations to multi-unit groups across US.
Read more on TOST →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →